List of articles with "South San Francisco"

Michael P. Miller Joins Rigel

Michael P. Miller Joins Rigel

USA South San Francisco Rigel Pharmaceuticals Biotech Leadership Mike Miller
Employee Stock Options

Employee Stock Options

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Amy Chase Becomes CCO

Amy Chase Becomes CCO

United States Customer Experience South San Francisco Nomis Solutions Amy Chase
FDA Fast Track for Gamgertamig

FDA Fast Track for Gamgertamig

United States FDA South San Francisco Ouro Medicines Gamgertamig
Rigel's Business Update

Rigel's Business Update

United States South San Francisco Rigel Pharmaceuticals TAVALISSE GAVRETO
IDEAYA 2026 Goals

IDEAYA 2026 Goals

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
Rigel Inducement Grants

Rigel Inducement Grants

United States biotechnology South San Francisco Rigel Pharmaceuticals Inducement Grants
InterVenn and Aranscia Partnership

InterVenn and Aranscia Partnership

United States South San Francisco Aranscia InterVenn Biosciences GlycoKnow
ABS Bio Acquires Cureline

ABS Bio Acquires Cureline

USA biotechnology South San Francisco ABS Bio Cureline
Key Milestone in Uveal Melanoma

Key Milestone in Uveal Melanoma

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
IDE574 Submission

IDE574 Submission

USA Cancer Treatment IDEAYA Biosciences South San Francisco IDE574
Ouro Medicines Receives FDA Designation

Ouro Medicines Receives FDA Designation

United States South San Francisco Ouro Medicines FDA Orphan Drug Gamgertamig
R289 for Lower-Risk MDS

R289 for Lower-Risk MDS

United States South San Francisco Rigel Pharmaceuticals R289 MDS
Cancer Initiative Expansion

Cancer Initiative Expansion

United States Cancer Prevention South San Francisco Human Longevity Colon Cancer
New DNA Data Storage

New DNA Data Storage

USA South San Francisco DNA Storage Atlas Data Storage Atlas Eon 100
3D Terrain Integration

3D Terrain Integration

United States South San Francisco ICEYE Aechelon Vantor
IDEAYA's FDA Clearance

IDEAYA's FDA Clearance

United States cancer therapy ADC South San Francisco IDE034
IDEAYA Stock Options

IDEAYA Stock Options

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Rigel at Healthcare Conf.

Rigel at Healthcare Conf.

United States South San Francisco Health Innovations Rigel Pharmaceuticals Nasdaq RIGL
IDEAYA Investor Events

IDEAYA Investor Events

USA oncology IDEAYA Biosciences South San Francisco Precision Medicine
Five-Year Findings on REZLIDHIA

Five-Year Findings on REZLIDHIA

United States South San Francisco Rigel Pharmaceuticals REZLIDHIA mIDH1 AML
Rigel at Jefferies

Rigel at Jefferies

United States Cancer Research South San Francisco Rigel Pharmaceuticals Hematologic Disorders
Rigel Q3 2025 Update

Rigel Q3 2025 Update

United States South San Francisco Rigel Pharmaceuticals R289 TAVALISSE
IDEAYA Q3 2025 Update

IDEAYA Q3 2025 Update

United States oncology IDEAYA Biosciences South San Francisco darovasertib
Rigel ASH Presentations 2025

Rigel ASH Presentations 2025

United States South San Francisco Rigel Pharmaceuticals R289 mIDH1 AML
IDEAYA Stock Options Grants

IDEAYA Stock Options Grants

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Darovasertib Trial Results

Darovasertib Trial Results

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
Life-Saving Results

Life-Saving Results

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
FDB MCP Server Launch

FDB MCP Server Launch

USA South San Francisco FDB MCP Server Clinical Decision Support
Calico's New Head of Discovery

Calico's New Head of Discovery

United States South San Francisco Drug Discovery Calico Life Sciences Philip R. Kym
Ouro's OM336 Expansion

Ouro's OM336 Expansion

United States South San Francisco Ouro Medicines Sjögren's Disease OM336
Revolutionary RNA-Seq Service

Revolutionary RNA-Seq Service

United States South San Francisco gene expression Plasmidsaurus RNA-Seq
ESSA and XenoTherapeutics Deal

ESSA and XenoTherapeutics Deal

United States biotechnology ESSA Pharma South San Francisco XenoTherapeutics
R289 Study Enrollment

R289 Study Enrollment

United States South San Francisco Rigel Pharmaceuticals R289 MDS
ESSA Acquired by Xeno

ESSA Acquired by Xeno

USA Acquisition ESSA Pharma South San Francisco XenoTherapeutics
Rigel Inducement Grants

Rigel Inducement Grants

USA stock options South San Francisco Rigel Pharmaceuticals restricted stock
Fast Track for ADPKD

Fast Track for ADPKD

United States South San Francisco ADPKD Calico Life Sciences ABBV-CLS-628
SCARS Database Initiative

SCARS Database Initiative

United States South San Francisco Aechelon Technology Project Orbion SCARS
IDEAYA Inducement Grants

IDEAYA Inducement Grants

United States NASDAQ stock options IDEAYA Biosciences South San Francisco
Dualitas Raises $65 Million

Dualitas Raises $65 Million

United States South San Francisco bispecific antibody Dualitas Therapeutics immune diseases
ESSA Pharma Meeting Postponed

ESSA Pharma Meeting Postponed

United States ESSA Pharma South San Francisco NASDAQ EPIX XenoTherapeutics
Project Orbion Launched

Project Orbion Launched

USA Digital Twin South San Francisco Aechelon Technology Project Orbion
Project Orbion Unveiled

Project Orbion Unveiled

USA Digital Twin South San Francisco Aechelon Technology Project Orbion
IDE397 Trial Results

IDE397 Trial Results

United States IDEAYA Biosciences South San Francisco Trodelvy IDE397
Positive Data for Darovasertib

Positive Data for Darovasertib

United States IDEAYA Biosciences South San Francisco uveal melanoma darovasertib
IDE849 Phase 1 Results

IDE849 Phase 1 Results

USA IDEAYA Biosciences South San Francisco Hengrui Pharma IDE849
First Patient in Lung Cancer Trial

First Patient in Lung Cancer Trial

United States IDEAYA Biosciences South San Francisco NSCLC Trodelvy
IDE892 IND Submission

IDE892 IND Submission

United States IDEAYA Biosciences South San Francisco PRMT5 Inhibitor IDE892
IDEAYA's Melanoma Data

IDEAYA's Melanoma Data

United States South San Francisco IDEAYA darovasertib crizotinib
IDEAYA Inducement Grants

IDEAYA Inducement Grants

United States NASDAQ stock options IDEAYA Biosciences South San Francisco

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.